Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions by Li Xiao et al.
RESEARCH Open Access
Expression of SOX2, NANOG and OCT4
in a mouse model of lipopolysaccharide-
induced acute uterine injury and
intrauterine adhesions
Li Xiao1,2†, Yong Song1,2†, Wei Huang1,2*, Shiyuan Yang1,2, Jing Fu1,2, Xue Feng1,2 and Min Zhou1,2
Abstract
Background: Activation of inflammation-mediated endometrial injury is suggested to play a decisive role in
pathogenesis of intrauterine adhesion (IUA). The stem cell theory of endometrial diseases has been given a
hotspot, in that human endometrial stem cells have been isolated from the endometrium. Three transcription
factors that play key roles in maintaining pluripotency and self-renewal in stem cells are sex-determining region
Y-box2 (SOX2), Nanog homebox (NANOG), and octamer-binding protein (OCT4), which may be responsible for
the damage or repair process of uterine endometrium. We aim to investigate the expression of SOX2, NANOG
and OCT4 in a mouse model of acute uterine injury induced by peritoneal injection of lipopolysaccharide (LPS)
and also analyze their changes in endometrium of women with IUA.
Methods: The mouse uterine horns were collected at 0 h, 6 h, 12 h, 18 h or 24 h after a single dose of LPS or
PBS injection. Meanwhile, we recruited 19 women with IUA diagnosed by hysteroscopy and 16 disease-free
women as control group. Endometrial tissue samples were collected. SOX2, NANOG, and OCT4 expression were
analyzed with Quantitative Real-time Polymerase Chain Reaction and Western blotting assay.
Results: In a mouse model of acute uterine injury, there was significant upregulation of NANOG at 6 h, SOX2 and
OCT4 at 12 h compared with the values before injection or PBS injection. NANOG expression reached a peak at
6 h, while SOX2 and OCT4 peaked later at 12 h after LPS treatment. NANOG mRNA and protein expressions were
significantly higher in endometrium of IUA patients compared to those of the control group.
Conclusions: Expression of pluripotency factors SOX2, NANOG and OCT4 increased in a mouse model of LPS-induced
acute uterine injury. NANOG peaked earlier followed by the other two factors before returning to baseline levels. NANOG
but not SOX2 and OCT4 expression was overexpressed in the endometrium of women with IUA. They may be involved
in the formation or restoration of IUA, and their roles in pathogenesis of IUA need to be further studied.
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Background
Intrauterine adhesion (IUA) comprises a less severe
condition involving partial replacement of endometrial
surfaces with fibrotic tissue. Presenting symptoms are
related to the degree and location of IUA, and include
menstrual abnormalities ranging from irregular bleeding
to hypomenorrhea and amenorrhea, infertility and/or re-
current pregnancy loss [1]. Normal endometrial growth
is essential for embryo implantation and maintenance of
pregnancy. IUA occurs most commonly as a result of
trauma or infection, particularly after pregnancy when
estradiol levels are low. Infection and inflammation may
contribute to the inability of traumatized endometrium
to regenerate and are important processes involved in
the deposition of fibrotic tissue [2].
Recently, a population of epithelial progenitor cells
and mesenchymal stem cells (MSCs) were identified in
human endometrium [3]. They are proposed to be re-
sponsible for regenerating the functional layer of the
endometrium following menstruation and parturition
[4]. Human MSCs are used in clinical trials as cell
source for tissue regenerative therapy. Recently, they are
known to have therapeutic benefits by regulating the im-
mune system invoked in settings such as tissue injury
and autoimmunity. MSCs suppress the immune response
by several different means, for instance, by secreting anti-
inflammatory cytokines such as IL-10 and TGF-β and the
inhibition of pro-inflammatory cytokines such as IL-6 and
TNF-α [5–7]. Single or repeated biopsy of the thin
endometrium induce an injury response that stimulates
resident endometrial stem/progenitor cells to initiate a
regenerative response and restore endometrial tissue
homeostasis [2]. Human endometrial Side Population (SP)
cells, a component of putative progenitor/stem cells,
rapidly accumulated in mice endometrium during acute
uterine injury induced by lipopolysaccharide (LPS) [8].
Though the acute inflammatory response may be benefi-
cial to the endometrium, in IUA the inflammation is self-
perpetuating and persists for a long period and can trigger
abnormal endometrial functions to facilitate the formation
of fibrosis and adhesion.
However, with lack of specific surface markers for
endometrial stem cells and the technical restrictions on
endometrial tissue samplings, researches on mesenchy-
mal stem/progenitor cells in endometrial diseases, espe-
cially in IUA, are scarce. Related studies mainly focus on
stem-ness related genes. Increasing evidence suggests
that three transcription factors: sex-determining region
Y-box 2 (SOX2), Nanog homeobox (NANOG), and
octamer-binding protein 4 (OCT4)are most frequently
involved in endometrial diseases [9–11]. SOX2, NANOG
and OCT4 cooperatively maintain the regulatory network
and play a pivotal role in maintaining the pluripotency
and self-renewal of stem cells [12]. They co-occupy and
regulate many developmentally important home domain
genes and collaborate to form an extensive regulatory cir-
cuitry including auto-regulatory and feed-forward loops
[13]. However, their role in acute uterine injury, as well as
in women with IUA have not been identified. Therefore,
we aimed to investigate the changes in expression of
SOX2, NANOG, and OCT4 using a mouse model of
acute uterine injury induced by peritoneal LPS injec-
tion. We also investigated these stem-ness related genes
in the endometrium of reproductive-age women with
or without IUA.
Methods
Uterine acute inflammation mouse model
This study was carried out in strict accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Ethics Committee of
West China University Hospital of Sichuan University.
Female BALB/c mice aged 8–16 weeks were purchased
from Chengdu Dashuo Experimental Animals Limited
Company (Chengdu, Sichuan, China). All animals were
housed in filter-top cages with autoclaved bedding,
autoclaved food and water ad libitum, and a 12 h light/
dark cycle.
BALB/c mice were grouped into two: Control and LPS
injected groups. A single dose of. LPS (0.5 mg/kg,
Sigma-Aldrich, St. Louis, MO, USA) was injected intra-
peritoneally to BALB/c mice to cause endometrial injury
[14]. Control mice were injected with an equal volume
of PBS. Mice were sacrificed by cervical dislocation at 6,
12, 18, 24 h and uterine horns were collected. Part of
specimens derived from LPS-treated and control mice
were fixed in formaldehyde and embedded in paraffin. 5
μm sections were cut and stained with hematoxylin and
eosin (H&E). Other Specimens were used for Quantitative
Real-time Polymerase Chain Reaction (qRT-PCR) and
Western blotting.
Human study population
The Ethical Committee of West China Second University
Hospital of Sichuan University approved the study and
informed consent was obtained from each participant.
Women aged ≤40 years with no hormonal treatment for
at least 3 months before surgery were included in the IUA
group. Similarly, women aged ≤40 years with regular men-
strual cycles and not taking hormonal treatment 3 months
before surgery and with no evidence of intrauterine adhe-
sions were included in the control group, The exclusion
criteria included endometriosis, adenomyosis, leiomyo-
mas, hydrosalpinx, endometrial polyp, endometrial hyper-
plasia, and acute pelvic inflammatory diseases. From
March 2014 to October 2014, we recruited 35 women
who had undergone simultaneous hysteroscopy and
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laparoscopy for this study. Of these, 19 women with
intrauterine adhesions were diagnosed by hysteroscopy
and further confirmed by pathology. The r-AFS intra-
uterine adhesion score standard was used for disease
stage (11 stage mild and 8 stage moderate) [15]. The
remaining 16 were controls that had undergone simul-
taneous laparoscopy and hysteroscopy for infertility
that had no visible evidence of intrauterine adhesions
during surgery (Table 1). Endometrial tissues were ob-
tained by scraping the endometrium with a uterine cur-
ette during hysteroscopic procedure from the adhesion
sites of IUA and control patients. Of the 19 IUA speci-
mens, 13 were used for qRT-PCR and remaining six for
Western blotting. Of the 16 control specimens, 11 were
used for qRT-PCR and remaining five for Western blot-
ting. Tissues were stored in a microfuge tube at −80 °C for
qRT-PCR and Western blotting analysis, or immediately
fixed in 10% buffered formalin and paraffin-embedded for
H&E staining. All participants were determined to be in
the proliferative phase of their menstrual cycle as assessed
by the timing of their last menstrual period and histo-
logical examination.
RNA extraction, reverse transcription, and quantitative
real-time polymerase chain reaction
All the tissue samples were frozen in liquid nitrogen im-
mediately after collection. Total RNA was extracted using
TRIzol, according to the manufacturer’s instructions (Life
Technologies Inc., Carlsbad, CA, USA) and, the quality
and concentration of purified RNA were analyzed using
Nano Drop Plus spectrophotometer (Health-careBio-
Science AB, Uppsala, Sweden). The nucleotide to
protein ratios (A260:A280) of all samples were within
the acceptable boundaries of 1.8 and 2.1. First-strand
complementary DNA (cDNA) was synthesized using
Prime Scriptreverse transcription (RT) Reagent Kit
(TaKaRa Biotechnology, Dalian, China) at 37 °C for
15 min, followed by deactivation at 85 °C for 5 s,
according to the manufacturer’s protocol. The primer
sequences were synthesized by Sangon Biotech (Shanghai,
China) and described in Table 2. cDNA was amplified using
EvaGreen Supermix (Bio-Rad Laboratories, Hercules, CA,
USA). Amplification was performed by initial denaturation
at 95 °C for 30 s followed by 40 cycles of denaturation at
95 °C for 5 s and annealing/elongation at 60 °C for 10 s.
Melting curve analysis confirmed the amplification of a
single product. The qRT-PCR assays were performed in
duplicate in three independent experiments for each
experimental condition. Human or mouse glyceraldehyde-
3-phosphate dehydrogenase (GADPH) was used for
normalization of the qRT-PCR results.
Western blotting
Total protein was collected using radio immunoprecipi-
tation lysis buffer (P0013B, Beyotime Biotechnology,
Shanghai, China) according to the manufacturer’s in-
structions. Protein concentration was determined using
a bicinchoninic acid assay kit (Beyotime Biotechnology).
Protein (30 μg) were separated using 10% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and
transferred to polyvinylidene fluoride membranes (Millipore,
Billerica, MA, USA). The membranes were blocked for 1 h
in 5% defatted milk at room temperature. Subse-
quently, the membranes were incubated with mono-
clonal mouse anti-human SOX2 (1:400; ab75485, Abcam,
Cambridge, UK), polyclonal rabbit anti-human NANOG
(1:400; ab80892, Abcam), OCT4 (1:800; ab18976, Abcam),
and polyclonal mouse anti-β-actin (1:30000; bs-2188R,
Bioss, Beijing, China) antibodies overnight at 4 °C.
Then the membranes were incubated with horseradish
peroxidase–conjugated secondary anti-mouse/rabbit
antibody for 1 h at room temperature. Proteins bands
were visualized using an enhanced chemiluminescence
system (Millipore) and analyzed with ImageJ 2x (National
Institutes of Health, Bethesda, MD, USA). Protein
levels were normalized to that of the internal control
β-actin.
Table 1 Characteristics of study population
Characteristics IUA group Non-IUA group
Number of cases (n) 19 16
Age (yrs.) 31.69 ± 4.35 (25 ~ 40) 29.27 ± 4.74 (23 ~ 36)




Table 2 Primer sequences used in quantitative real-time PCR in
human and mouse specimen
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Statistical analysis
Statistical analysis was performed using SPSS version
18.0 (SPSS, Chicago, IL, USA). All data are expressed as
means ± SEM. Differences between groups were analyzed
with one-way analysis of variance followed by a post hoc
test (Student–Newman–Keuls method). Statistical signifi-
cance was determined as P <0.05 (two-tailed).
Results
LPS induces uterine inflammation
Uterine endometrial injury was observed at 6–12 h after
LPS injection (Fig. 1a). It was characterized by the pres-
ence of edema macroscopically. and neutrophils (arrows)
in the uterine endometrial epithelium and stroma 6 h
after LPS injection. Repair of the endometrial injury was
evident by 24 h after LPS injection. The neutrophils were
significantly increased 6 h after LPS injection (P = 0.000
vs. 0 h), and returned to normal level before the injection
24 h after injection (Fig. 1b). Interleukin-6 (IL-6) mRNA
expression in mice uterine was significantly increased and
reached a peak at 6 h after LPS injection (P = 0.002 vs.
0 h). Expression of IL-6 mRNA decreased rapidly at 12 h,
and remained at a low level at 18 h and 24 h after LPS
injection (P = 0.812, 0.898, 0.888 vs. 0 h), which are not
significantly different compared to that before LPS or PBS
injection, hence the inflammatory reaction was not signifi-
cant since then (Fig. 2).
Expression of SOX2, NANOG, and OCT4 mRNA in
LPS-induced acute uterine injury
The NANOG mRNA sharply increased, peaking at 6 h
after LPS injection significantly (P = 0.02 vs. 0 h, P = 0.000
vs PBS). Then, the expression gradually decreased at 12,
18, and 24 h after LPS injection. The expression of SOX2
mRNA also increased in the uterus and reached a peak at
12 h after LPS injection. This was significantly higher at
12 h and 18 h (P = 0.01 vs. 0 h) and returned to baseline
after 24 h after LPS injection. Similar to the expression of
SOX2 mRNA, OCT4 mRNA increased after LPS injection,
and reached a peak at 12 h after LPS injection. There was
a significant difference only at 12 h after LPS injection and
returned to baseline after 24 h (P = 0.04 vs. 0 h) (Fig. 3).
Expression of SOX2, NANOG, and OCT4 proteins in
LPS-induced injured uterus
Western blotting demonstrated that the expression of
SOX2, NANOG, and OCT4 protein all increased after
LPS injection. Similar to the qPCR results, the expres-
sion of NANOG protein peaked at 6 h, SOX2 and
OCT4 protein peaked at 12 h after LPS injection, while
after LPS injection. LPS injection led to a significant
increase in SOX2 protein in mice uterine at 6 h, 12 h
after LPS injection (P = 0.04, P = 0.04 vs. 0 h), NANOG
protein in mice uterine at 6 h, 12 h after LPS injection
Fig. 1 LPS-induced uterine endometrial injury. a The gross uterine specimen and histological finding of uterine endometrium. Sections of uterine
endometrium were obtained and stained with H&E. Edema and neutrophils (arrows) were observed in the endometrial epithelium and stroma.
b The percentage of neutrophils in the uterine endometrium. The percentage increased significantly in mice uterine and peaked at 6 h after LPS
injection. Values are represented as mean ± SEM. ★★★P <0.001 vs.0 h
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(P = 0.001, P = 0.001vs. 0 h) and OCT4 protein at 12 h
after LPS injection (P = 0.02 vs. 0 h) (Fig. 4).
SOX2, NANOG, and OCT4 mRNA and protein expression
in the endometrium of women with IUA
NANOG mRNA expression in the endometrium of IUA
women was significantly higher than that in normal
endometrium (P = 0.008). No significant differences were
observed in the expression of SOX2 and OCT4 genes in
the IUA endometrium compared to the normal endo-
metrium (P >0.05) (Fig. 5). Similarly, NANOG protein
expression in the endometrium of IUA women was
significantly increased compared to the normal endo-
metrium, (P = 0.035). SOX2 and OCT4 protein expres-
sion in IUA endometrium tended to be higher, but were
not statistically significant (P >0.05) (Fig. 6).
Discussion
Murine endometrium consists of a single layer that con-
tains epithelium and stroma [16]. Therefore, the murine
endometrium is considered a suitable model of uterine
endometrial research. Mounting evidence suggests that
the evolutionarily adaptive process of acute inflamma-
tion, which is needed for wound-healing or eliminating
after uterine curettage or operation, can be maladaptive
if it is sustained chronically. Thus, LPS, the major compo-
nent of endotoxin in gram-negative bacterial infection, can
enter the blood stream and elicit systemic inflammatory re-
sponse with increased production of pro-inflammatory me-
diators such as IL-6 [17]. We established a mouse model of
acute uterine injury to explore expression of stem cell and
proteins response to acute inflammation over a 24 h time
period to understand the initial acute phase of IUA. To our
knowledge, this study provides the first evidence that LPS
induced acute inflammation provokes a rapid increase in
transcription factor SOX2, NANOG and OCT4 mRNA
and protein levels in the uterus. These upregulated changes
returned to baseline within 24 h. It is therefore conceivable
that tissue injury could induce a temporary increase in
SOX2, NANOG and OCT4 at mRNA and protein levels.
Upregulation of these transcriptional factors in corres-
pondence with inflammatory response and their levels
recovering following subsidence of inflammation suggests
that these factors may contribute to the endometrial
regeneration following an acute insult.
Taylor el al. have reported that progenitor/stem cells
might reside in the uterine endometrium with or with-
out injury and may differentiate into uterine endometrial
stroma and epithelium [18]. This is compatible with our
findings that stem-ness related genes were present even
in the absence of injury, and injury increased transcrip-
tional factor SOX2, NANOG and OCT4 in mouse uterus.
A previous study demonstrated that SP cells, a cluster of
stem/progenitor cell in adult tissue [19], rapidly accumu-
lated in a mouse model of LPS-induced endometrial injury.
Endometrial injury could not only stimulate residence
progenitor/stem cells proliferation but also attract and pro-
mote migration of bone marrow stem cells to the endo-
metrium [4, 18, 20]. As it is suggested that the progenitor/
stem cells could be responsible for the cyclical regeneration
of the uterine endometrium [21], and the stem-ness related
Fig. 2 Changes of IL-6 mRNA expression in mice injured uterine injected
with LPS or PBS (control). Analysis was carried out on mice uterine
before injection, after LPS or PBS injection. The expression of IL-6 mRNA
increased significantly in mice uterine and peaked at 6 h after LPS
injection. Values are represented as mean ± SEM. ★★P <0.005 vs.0 h,
ɸɸP <0.005vs. PBS
Fig. 3 qRT-PCR analysis of SOX2, NANOG, and OCT4 mRNA in mice injured uterine injected with LPS or PBS (control). a-c) Analysis was carried out
on mice uterine before injection (n = 5), after LPS (6 h, n = 6; 12 h, n = 6; 18 h, n = 5; 24 h, n = 5) or PBS (6 h, n = 4; 12 h, n = 4; 18 h, n = 4; 24 h,
n = 4) injection. Values are represented as mean ± SEM. ★★P <0.005 vs.0 h, ★P <0.05 vs.0 h, ɸP <0.05vs. PBS
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genes, which play a key role in maintaining the pluripo-
tency and renewable of stem cells, could be also re-
sponsible for the rapid regeneration of endometrium
during menstruation or injury. NANOG was observed
to attenuate inflammatory response of BV-2 cells [22]
and rat primary microglial cells [23] stimulated by LPS.
It also inhibits the NO release, iNOS expression and
pro-inflammatory mediators IL-6, IL-1β and TNF-α, by
blocking NF-kB transcriptional activity, that supporting
NANOG may be the mechanism for reduction of pro-
inflammatory factors. However, SOX2 overexpression
upregulated genes associated with tissue damage and
inflammation, including IL-1β and IL-6, and it cooper-
ates with inflammatory signaling mediated through the
IL-1β/IL-6/Stat3 pathway, to transform progenitor cells
[24]. Regardless, our finding of those stem transcription
factors expression in mouse model speculates for the
first time that the acute injury seems to be the triggering
event in mouse uterus that initiate an up-regulation of
stem-ness related genes, which may be a potential anti-
inflammatory therapy or the pathogenesis of endometrial
inflammation related diseases.
On the other hand, It is well known that 90% of genes
with promoters bound by OCT4 and SOX2 in human
ESCs are also bound by NANOG [25], Originally, we
found it intriguingly that an immediate rapid rise in
NANOG expression, which reached a peak at 6 h,
followed by a rise in SOX2 and OCT4 genes, with peak
up-regulation at 12 h after LPS treatment. Therefore,
consistent with our data, Chambers and coworkers have
also shown that it is possible that NANOG may allevi-
ate the requirement for SOX2 in reprogramming by
Fig. 4 Western Blotting analysis of SOX2, NANOG, and OCT4 protein in mice injured uterine injected with LPS. a-c Analysis was carried out on
mice uterine before injection (n = 3) and after LPS injection (6 h, n = 4; 12 h, n = 4; 18 h, n = 3; 24 h, n = 3). Values are represented as mean ± SEM.
★★P <0.005 vs.0 h, ★P <0.05 vs.0 h. d Representative western blotting of SOX2, NANOG, and OCT4 protein. β-actin, internal control
Fig. 5 qRT-PCR analysis of SOX2, NANOG, and OCT4 mRNA in IUA or
normal endometrium. Analysis was carried out on normal endometrium
(n= 11) and IUA endometrium specimens (n= 13). ★★P<0.05. Values are
represented as mean ± SEM, Error bars denote SEM
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stimulating or maintaining OCT4 expression. Indeed,
NANOG can maintain OCT4 expression in mESCs [26].
It is reported that NANOG expression enhanced the re-
programming of human fibroblasts but that it was not
able to replace SOX2 in the presence of only OCT4 and
LIN-28 [27]. We have shown that there may be a delay for
SOX2 and OCT4 to regulate downstream genes chrono-
logically, following by NANOG, which could be a trigger
for other two factors, and the specific mechanism need to
be further studied.
In this study, we have endeavored to systematically
investigate the expression and origin of transcriptional
factors in IUA. The expression of NANOG mRNA and
protein, and that of two other core stem cell transcrip-
tion factors, SOX2 and OCT4, were detected in IUA
endometrium [11]. We showed significantly higher
expression of NANOG mRNA in IUA endometrium as
well as NANOG protein, when compared with normal
endometrium. The increasing NANOG expression in
our study may indicate stem cell origin pathological
mechanism of IUA. Recent studies have demonstrated a
key role for the NANOG gene in maintaining pluripo-
tency and self-renewal of stem cells [26]. Overexpression
of mouse or human NANOG in ES cells can overcome
the requirement for leukocyte inhibitor factor to maintain
the undifferentiated state and can block differentiation in
the presence of retinoic acid or3-methoxybenzamide,
while the deletion of NANOG gene resulted in loss of
pluripotency in both ICM and ESCs [16, 26]. Compared
to the all three transcriptional factors overexpression in
the acute inflammatory response, the upset of balance
between pro-inflammation and anti-inflammation, me-
diated by those transcription factors may be the break-
through of IUA, which only overexpressed NANOG.
When given a single dose of LPS treatment, the related
transcription factors and their network may play a role
in endometrial inflammation and repair. OCT4 and
SOX2 cooperatively bind many genomic sites as hetero-
dimers. NANOG binding also shows extensive overlap
with that of OCT4 and SOX2 [28]. However, there may
be functional differences between OCT4 and SOX2
modules and the NANOG module, as they also regu-
lated independently different down-stream target genes
[26, 29]. In case of IUA with higher levels of NANOG,
there is persistent chronic inflammation. The changes of
OCT4-SOX2-NANOG occupancy do not correlate well
with differential gene expression. Thus, the intercon-
nected network may be broken down, and NANOG
function independently leading to stem cells differenti-
ation into myofibroblast and formation of endometrial
fibrosis. We believe that this may be a potential mech-
anism that leads to the intrinsic differentiation of
endometrial stem cells, and play a vital role in the
pathogenesis of disease, thus supporting the “stem cell”
hypothesis of IUA.
The present study has some limitations and unanswered
questions that need to be addressed to improve upon
future studies. First, sample size is not large and amount
of endometrial tissue, especially endometrial tissues from
IUA are extremely bare, cannot match all experimental
items that may result in some index not reach statistical
significance. Second, this study only demonstrated the in-
creased expression of transcription factors. It would be
important to confirm the specific mechanism of their roles
in IUA, an inflammatory endometrial disease. Studies on
larger sample size in future would be helpful in under-
standing the molecular mechanism of SOX2, NANOG
and OCT4 in IUA.
Fig. 6 Western blotting analysis of SOX2, NANOG, and OCT4 protein in IUA or normal endometrium. a Analysis was carried out on normal endometrium
(n= 5) and IUA endometrium specimens (n= 6). ★★P<0.05. Values are represented as mean ± SEM; Error bars denote SEM. b Representative Western
Blotting of SOX2, NANOG, and OCT4 protein. β-actin, internal control
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Conclusions
In acute inflammatory mouse model, the expression of
transcriptional factors, SOX2, NANOG and OCT4 in
the uterus peaks and levels off to base line after the in-
flammation subsides. This may be vital response in an
acute insult for tissue repair and regeneration. However,
only NANOG is overexpressed in the endometrium of
reproductive-age women with IUA. This may suggest a
mismatch in cross-talk between NANOG with OCT4
and SOX2 in IUA leading to failure/faulty in endometrial
repair and replacing with fibrotic tissue. Further studies
should be required to identify the specific transcriptional
factors’ role in pathogenesis of IUA. However, it will be
of significant interest to determine these transcription
factors could be involved in the formation or restoration
of IUA, as well as in acute uterine injury.
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